Publications of U. Reichl

Poster (335)

2009
Poster
Lohr, V.; Genzel, Y.; Jordan, I.; Sandig, V.; Reichl, U.: Characterization of avian designer cells as substrates for MVA production. 21st ESACT Meeting, Dublin, Ireland (2009)
Poster
Rath, A.; Genzel, Y.; Sandig, V.; Rose, T.; Reichl, U.: Strategies For Batch Cultivation Of Two New Human Suspension Cell Lines: Culture Conditions And Cellular Metabolism. BioSys2009, Hamburg, Germany (2009)
Poster
Rath, A.; Genzel, Y.; Sandig, V.; Rose, T.; Reichl, U.: A Novel Human Designer Cell Line: Metabolism During Cell Growth. ProcessNet-Jahrestagung 2009 und 27. Jahrestagung der Biotechnologen, Mannheim, Germany (2009)
Poster
Rath, A.; Genzel, Y.; Sandig, V.; Rose, T.; Reichl, U.: Cell Growth and Metabolism of a Novel Human Designer Cell Line. 21st ESACT Meeting, Dublin, Ireland (2009)
Poster
Riedele, C.; Geisler, L.; Reichl, U.: Antibiotic Pulse Experiments in a 3-Species Mixed Culture. VAAM 2009 - Jahrestagung der Vereinigung für Allgemeine und Angewandte Mikrobiologie, Bochum, Germany (2009)
Poster
Roedig, J.; Rapp, E.; Hennig, R.; Schwarzer, J.; Reichl, U.: Optimized CGE-LIF-based glycan analysis for high-throughput applications. 21st ESACT Meeting, Dublin, Ireland (2009)
Poster
Roedig, J.; Rapp, E.; Schwarzer, J.; Genzel, Y.; Reichl, U.: Impact of viral adaption on the N-glycosylation pattern of Influenza A hemagglutinin. ProcessNet-Jahrestagung 2009 und die 27.Jahrestagung der Biotechnologen , Mannheim, Germany (2009)
Poster
Rüger, M.; Reichl, U.: Flow cytometric analysis of a medically relevant microbial community using species-specific immunofluorescence probes and DNA staining. DGFZ 2009, Leipzig, Germany (2009)
Poster
Rüger, M.; Reichl, U.: Single cell analysis of a cystic fibrosis relevant bacterial community using immuno detection by flow cytometry. Flow Cytometry 2009, Oxford UK (2009)
Poster
Schulze-Horsel, J.; Isken, B.; Bock, A.; Genzel, Y.; Reichl, U.: Monitoring of host-cell infection and apoptosis in influenza vaccine production. 21st ESACT Meeting, Dublin, Ireland (2009)
Poster
Seitz, C.; Frensing, T.; Reichl, U.: Analysis of Interferon Induction in Mammalian Cells during Influenza Virus Production. 27. Jahrestagung der Biotechnologen, Mannheim (2009)
Poster
Seitz, C.; Frensing, T.; Reichl, U.: Influence of the innate immune response on mammalian cell culture based influenza vaccine production. 21st ESACT Meeting , Dublin, Ireland (2009)
Poster
Seitz, C.; Frensing, T.; Reichl, U.: The role of the type I interferon response in mammalian cell culture based influenza vaccine production. 19th Annual GfV Meeting, Leipzig (2009)
Poster
Vester, D.; Rapp, E.; Genzel, Y.; Reichl, U.: Virus-host cell interactions in a vaccine manufacturing process: Proteomics of production cell lines in response to human influenza A virus infection. 21st ESACT Meeting, Dublin, Ireland (2009)
Poster
Wolff, M.; Siewert, C.; Lehmann, S.; Hansen, S.P.; Faber, R.; Reichl, U.: Cellufine Sulfate and heparin affinity chromatography to capture ce culture-derived Vaccinia virus particles. 21th ESACT Meeting, Dublin, Ireland (2009)
2008
Poster
Bock, A.; Schulze-Horsel, J.; Schwarzer, J.; Genzel, Y.; Reichl, U.: The influence of elevated oxygen partial pressure on specific virus productivities in an influenza vaccine process. Vaccine Technology II, Albufeira, Portugal (2008)
Poster
Heynisch, B.; Seitz, C.; Vester, D.; Frensing, T.; Reichl, U.: Systems Biology of Virus-Host Cell Interactions-Signal Transduction during Influenza Virus Replication in MDCK Cells. XIV. International Congress of Virology (IUMS 2008), Istanbul, Turkey (2008)
Poster
Janke, R.; Wahl, A.; Reichl, U.: Enzyme Activities in Central Carbon Metabolism of MDCK Cells under Different Growth Conditions. BioPerspectives, Hannover, Germany (2008)
Poster
Janke, R.; Wahl, A.; Reichl, U.: Determination of key enzyme activities in the central carbon metabolism of MDCK cells. ForSys Meeting, Berlin, Germany (2008)
Poster
Lohr, V.; Rath, A.; Genzel, Y.; Jordan, I.; Sandig, V.; Reichl, U.: Metabolism of avian designer cells during influenza and MVA production. Vaccine Technology II, Albufeira, Portugal (2008)
Go to Editor View